Clinical Trials Browser

Head and Neck Neoplasms × Ramucirumab × 90 days × Clear all

NCT05980000 2026-03-31

Rambro2

Phase 2 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms